Loss of heterozygosity (LOH) occurs commonly in some human tumors and is thought to reflect the selective pressure exerted by tumor suppressor genes. The purpose of this study was to examine the genomic location and relative frequency of LOH of chemically induced tumors in an established mouse model for chemical carcinogenesis. Twenty-four tumors were induced by subcutaneous injection of 3-methylcholanthrene into inter-subspecific hybrid (C57BL/6J x SPRET/Ei)F1 mice. Tumors were diagnosed as poorly differentiated, spindle cell sarcomas. DNA isolated from cell cultures derived from the sarcomas was analysed for LOH using a multi-locus genome scanning technique, motif-primed PCR, followed by conventional simple sequence length polymo...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
It has been difficult to genetically map the genes encoding tumor Ags because they arise as a conseq...
To identify potential involvement of tumor suppressor gene inactivation during leukemogenesis by Mol...
Mutations of the p53 tumor suppressor gene are the most common defined genetic alterations seen in a...
Alterations in oncogenes and tumor suppressor genes (TSGs) are considered to be critical steps in on...
The primary objective of this study has been to investigate the effects at the molecular level of tr...
We generated allelotypes of 38 methylene chloride-induced lung carcinomas from female C57BL/6J x C3H...
Deletions at multiple sites on the short arm of chr3 have been detected in many different types of h...
Allele loss and deletion mapping using microsatellite markers and the detection of homozygous deleti...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Loss of heterozygosity (LOH) occurs commonly in cancers causing disruption of tumor suppressor genes...
AbstractBreast tumors in (FVB × BALB-NeuT) F1 mice have characteristic loss of chromosome 4 and spor...
Breast tumors in (FVB × BALB-NeuT) F1 mice have characteristic loss of chromosome 4 and sporadic los...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
It has been difficult to genetically map the genes encoding tumor Ags because they arise as a conseq...
To identify potential involvement of tumor suppressor gene inactivation during leukemogenesis by Mol...
Mutations of the p53 tumor suppressor gene are the most common defined genetic alterations seen in a...
Alterations in oncogenes and tumor suppressor genes (TSGs) are considered to be critical steps in on...
The primary objective of this study has been to investigate the effects at the molecular level of tr...
We generated allelotypes of 38 methylene chloride-induced lung carcinomas from female C57BL/6J x C3H...
Deletions at multiple sites on the short arm of chr3 have been detected in many different types of h...
Allele loss and deletion mapping using microsatellite markers and the detection of homozygous deleti...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Loss of heterozygosity (LOH) occurs commonly in cancers causing disruption of tumor suppressor genes...
AbstractBreast tumors in (FVB × BALB-NeuT) F1 mice have characteristic loss of chromosome 4 and spor...
Breast tumors in (FVB × BALB-NeuT) F1 mice have characteristic loss of chromosome 4 and sporadic los...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
During tumor development, loss of heterozygosity (LOH) often occurs. When LOH is preceded by an onco...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...